The U.S. Food and Drug Administration (FDA) has approved Nesina (alogliptin) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.
Nesina is a dipeptidyl peptidase-4 inhibitor (DPP-4i) that is designed to slow the inactivation of incretin hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide).
Nesina Medication Guide
Read this Medication Guide carefully before you start taking Nesina and each time you get a refill. There may be new information. This information does not take the place of talking with your doctor about your medical condition or treatment.
If you have any questions about Nesina, ask your doctor or pharmacist.
What is the most important information I should know about Nesina?
Serious side effects can happen to people taking Nesina, including inflammation of the pancreas (pancreatitis) which may be severe.
Certain medical conditions make you more likely to get pancreatitis. Before you start taking Nesina:
Tell your doctor if you have ever had:
stones in your gallbladder (gallstones)
a history of alcoholism
Read More: http://www.drugs.com/nesina.html
Next Discussion: FDA Approves Oseni for Type 2 »